Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Furosemide
Bristol Laboratories Ltd
C03CA01
Furosemide
20mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 02020200; GTIN: 5060013940590 5060013940613
PRODUCT NAME DIMENSION NO OF COLOR FONT USED VERSION LANGUAGE SOFTWARE ARTWORK LEGEND FUROSEMIDE TABLETS 20MG, 40MG -S/L-ENG PIL 180 X 400 MM HUMANST521 BT ROMAN & BOLD-9PTS V4-23-9-19 ENGLISH ADOBE ILLUSTRATOR( CREATIVE CLOUD) 01- BLACK (FONTS USED IN LEGEND : ARIAL TYPE SIZE :10POINTS) inflammation and pain) or ACE inhibitors (medicines used to lower blood pressure) • you are elderly patient with dementia and are also taking risperidone • laboratory monitoring- it is recommended to under go regular monitoring of blood levels of sodium, pottasium, kidney function tests (blood urea nitrogen and creatinine levels), glucose, magnesium, calcium, chloride, bicarbonate and uric acid • regular monitoring is required to check for occurence of blood dyscrasias (abnormal or imbalance in blood components), liver damage or any symptom that may occur particularly to you. OTHER MEDICINES AND FUROSEMIDE TABLETS Do not take this medicine and tell your doctor, if you are taking: medicines which change the amount of potassium in your blood. These include potassium supplements such as potassium chloride or certain water tablets (diuretics) such as triamterene. Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines • Tell your doctor if you are taking the below medicines as the dose of these may need to be changed to avoid the risk of excessive lowering of blood pressure. Other blood pressure lowering agents (cardiac glyclosides eg. Digoxin, other diuretics that help you pass more urine; or other blood pressure lowering agents) • If you are taking any drugs that can be harmful to your kidneys • If you have low levels of potassium or magnesium in your blood indicated by the blood counts. A large number of drugs can interact with Furosemide which can significantly alter their effects. These drugs include: • Medicines such as ramipril, enalapril, perindopril (called ‘ACE inhibitors’) or losartan, candesartan, irbesartan (called ‘angiotensin II receptor antagonists’ Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Furosemide 20 mg Tablets BP 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 20 mg of Furosemide Excipient(s): Each tablet contains 52.5mg lactose monohydrate For the full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Tablet Round, white to off-white tablet embossed ‘F 20’ on one side and ‘’BL’’ on the other side. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Furosemide is a potent diuretic with rapid action. Furosemide tablets are indicated for: 1) The treatment of fluid retention associated with heart failure, including left ventricular failure, cirrhosis of the liver and renal disease, including nephrotic syndrome. 2) The treatment of mild to moderate hypertension (alone, or in combination with other antihypertensive agents in the treatment of more severe cases). 4.2 POSOLOGY AND METHOD OF ADMINISTRATION It is recommended that Furosemide tablets are taken on an empty stomach, and with plenty of liquid. Adults: The initial adult dose is 40mg daily, reduced to 20mg daily or 40mg on alternative days. In some patients daily doses of 80mg or higher (given in divided doses) may be required. Children: Contra-indicated (see section 4.3) Elderly: Caution is advised as furosemide is eliminated more slowly in elderly patients.Treatment should be started with 20mg and titrated upwards as required (see section 4.4). Method of Administration: For oral administration 4.3 CONTRAINDICATIONS • Hypersensitivity to furosemide or any of the excipients of this product. • Hypersensitivity to amiloride, sulphonamides or sulphonamide derivatives (because of cross-sensitivity between sulphonamides and furosemide). • Hypovolaemia or dehydration (with or without accompanying hypotension) (see section 4.4) • Anuria, or renal failure with anuria not responding to furosemide. • Renal failure as a result of poisoning by nephrotoxic or hepatotoxic agents or renal failure associated with hepatic coma. • Pre-comatose and co Read the complete document